SCHEMBL2028634

SCHEMBL2028634

C=C(C)C(=O)OC(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL65534 0.87 TSHR (0.42) TSHRALDH1A1
SCHEMBL952948 0.85 TSHR (0.41) TSHRALDH1A1
SCHEMBL9559905 0.81 ALDH1A1 (0.41) TSHRALDH1A1
SCHEMBL9560048 0.81 ALDH1A1 (0.41) TSHRALDH1A1
SCHEMBL322652 0.81 TSHR (0.41) TSHRALDH1A1
SCHEMBL63713 0.81 TSHR (0.41) TSHRALDH1A1
SCHEMBL4336062 0.80 HCAR2 (0.31)
SCHEMBL27492219 0.77 TSHR (0.39) TSHRALDH1A1
SCHEMBL11806871 0.76 TSHR (0.37) TSHRALDH1A1
SCHEMBL538063 0.76 TSHR (0.50) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4861840-A Novel siloxanyl acrylic monomer and gas-permeable contact lenses made therefrom BARNES-HIND, INC. (US) 1989-08-29 US claimed
JP-63253091-A None JP disclosed
EP-4097155-B1 ACTINICALLY-CROSSLINKABLE POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF CLEARLAB SG PTE LTD (SG) 2025-08-20 EP disclosed
US-12037463-B2 Antimicrobial ophthalmic devices comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof Clearlab Sg Pte Ltd. (SG) 2024-07-16 US disclosed
US-12024597-B2 Wound dressings comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof Clearlab Sg Pte Ltd. (SG) 2024-07-02 US disclosed
US-20230227613-A1 ANTIMICROBIAL OPHTHALMIC DEVICES COMPRISING POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF CLEARLAB SG PTE LTD (SG) 2023-07-20 US disclosed
US-20230212357-A1 WOUND DRESSINGS COMPRISING POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF CLEARLAB SG PTE LTD (SG) 2023-07-06 US disclosed
US-11649325-B2 Actinically-crosslinkable polysiloxane-polyglycerol block copolymers and methods of making and use thereof Clearlab Sg Pte Ltd. (SG) 2023-05-16 US disclosed
EP-4097155-A1 ACTINICALLY-CROSSLINKABLE POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF Clearlab SG Pte Ltd (SG) 2022-12-07 EP disclosed
US-20210246270-A1 ACTINICALLY-CROSSLINKABLE POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF Clearlab Sg Pte Ltd. (SG) 2021-08-12 US disclosed
US-10329486-B2 Cyanostilbenes ROLIC AG (CH) 2019-06-25 US disclosed
EP-3004050-A1 CYANOSTILBENES Rolic AG (CH) 2016-04-13 EP disclosed
US-20160083655-A1 CYANOSTILBENES ROLIC AG (CH) 2016-03-24 US disclosed
WO-2014191292-A1 CYANOSTILBENES ROLIC AG (CH) 2014-12-04 WO disclosed
US-7959990-B2 Adjustment of liquid crystals; oligomers, dendrimers, or polymer in solution is applied to support; crosslinking by radiation or polarized light ROLIC AG (CH) 2011-06-14 US disclosed
US-20080274304-A1 Functionalized Photoreactive Compounds ROLIC AG (CH) 2008-11-06 US disclosed
EP-1764405-A1 Functionalized photoreactive compounds Rolic AG (CH) 2007-03-21 EP disclosed
US-4948855-A COPOLYMER OF UNSATURATED SILOXANYLALKOXYESTER AND VINYL SILFONE PROGRESSIVE CHEMICAL RESEARCH, LTD. (CA) 1990-08-14 US disclosed
US-4861840-A Novel siloxanyl acrylic monomer and gas-permeable contact lenses made therefrom BARNES-HIND, INC. (US) 1989-08-29 US disclosed
JP-S63253091-A ((METH)ACRYLOXYALKOXY)SILANE HAVING TRIMETHYLSILOXY GROUP TOSHIBA SILICONE CO LTD 1988-10-20 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274304-A1 Functionalized Photoreactive Compounds PCNA, PIN1, MAP1LC3C TSHR 4847/4885ALDH1A1 147/4885
US-20160083655-A1 CYANOSTILBENES LATS1, LATS2, CRY1 TSHR 4718/4885ALDH1A1 2838/4885
US-10329486-B2 Cyanostilbenes LATS1, LATS2, CRY1 TSHR 4718/4885ALDH1A1 2838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.